Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2022 | 36230542 | PubTator, text mining | PubMed |
| Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification. | BMC Cancer | 2022 | 36224530 | PubTator, text mining | PubMed |
| Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TGFβ2/ALK1 axis. | Exp Mol Med | 2022 | 36224344 | PubTator, text mining | PubMed |
| Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution. | Commun Biol | 2022 | 36224302 | PubTator, text mining | PubMed |
| Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. | Nat Commun | 2022 | 36216827 | PubTator, text mining | PubMed |
| Tear proteome profile in eyes with keratoconus after intracorneal ring segment implantation or corneal crosslinking. | Front Med (Lausanne) | 2022 | 36203781 | PubTator, text mining | PubMed |
| Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data. | BMC Med | 2022 | 36195867 | PubTator, text mining | PubMed |
| The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies. | PLoS One | 2022 | 36190999 | PubTator, text mining | PubMed |
| Calcifying fibrous tumor. | Autops Case Rep | 2022 | 36186113 | PubTator, text mining | PubMed |
| [A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene]. | Zhongguo Fei Ai Za Zhi | 2022 | 36172736 | PubTator, text mining | PubMed |
| Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis. | Infect Drug Resist | 2022 | 36172619 | PubTator, text mining | PubMed |
| Breast lymphomas, breast implants and capsules The timeline of BIA-ALCL with respect to surgical consent: the UK perspective. | JPRAS Open | 2022 | 36164587 | PubTator, text mining | PubMed |
| Giant primary low-grade fibromyxoid sarcoma arising from the left pulmonary parenchyma: A case report and literature review. | Cancer Rep (Hoboken) | 2022 | 36148539 | PubTator, text mining | PubMed |
| A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. | Front Immunol | 2022 | 36148224 | PubTator, text mining | PubMed |
| Screening Potential Diagnostic Biomarkers for Age-Related Sarcopenia in the Elderly Population by WGCNA and LASSO. | Biomed Res Int | 2022 | 36147639 | PubTator, text mining | PubMed |
| Mucins and CFTR: Their Close Relationship. | Int J Mol Sci | 2022 | 36142171 | PubTator, text mining | PubMed |
| Rational Approach to Finding Genes Encoding Molecular Biomarkers: Focus on Breast Cancer. | Genes (Basel) | 2022 | 36140706 | PubTator, text mining | PubMed |
| De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells. | Biomedicines | 2022 | 36140265 | PubTator, text mining | PubMed |
| Analysis of Human and Microbial Salivary Proteomes in Children Offers Insights on the Molecular Pathogenesis of Molar-Incisor Hypomineralization. | Biomedicines | 2022 | 36140166 | PubTator, text mining | PubMed |
| Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India. | PLoS One | 2022 | 36137153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=30